. >> crl color blindness is a defect in the sensing pigments. >> one that is sensitive to green and onensitive to red light you can notice the green and red overlap each other. >> for someone with a color deficiency the red and grown overlap so much they look basically brown, unless you can block a narrow part of the spectrum between brown and green. this orange flour will -- flower will finely stan out but for someone who is color deficient this goes way beyond plant life. the world is made out of colors and being able to tell them apart can be a matter of safety. if you can't see color, you're more likely to hesitate when you have to make a split second decision. the clean cal trials he says color blind patients made the snap judgment 30% faster. >> pointing out a lavender flower, never seen that color before in their life. that's the goo bump moment -- goose bump moment for me. >> you want to be able to see all the beautiful weather out there let's check in with meteorologist leigh glaser. >> leigh: going to be a terrific day tomorrow. although temperatures will be held down into the

. >> crl color blindness is a defect in the sensing pigments. >> one that is sensitive to green and onesitive to red light you can notice the green and red overlap each other. >> for someone with a color deficiency the red and grown overlap so much they look basically brown, unless you can block a narrow part of the spectrum between brown and green. this orange flour will -- flower will finely stan out but for someone who is color deficient this goes way beyond plant life. the world is made out of colors and being able to tell them apart can be a matter of safety. if you can't see color, you're more likely to hesitate when you have to make a split second decision. the clean cal trials he says color blind patients made the snap judgment 30% faster. >> pointing out a lavender flower, never seen that color before in their life. that's the goo bump moment -- goose bump moment for me. >> you want to be able to see all the beautiful weather out there let's check in with meteorologist leigh glaser. >> leigh: going to be a terrific day tomorrow. although temperatures will be held down into the

crl pats.3 % i'm not going to sit here and let you or anybody else kick [ bleep ] out of me without defendingf. and you can take that to the [ bleep ] bank, charlie. if you want to show me the door, that's fine, too. >>> three big names. a scandal in tabloid headlines. each told me their sordid stories, only one had me actually fearing for my safety. here's a moment from an interview like none i have ever done before and i hope i don't have to do again. my conversation with robert blake. do you remember the night that she died well or is it now something you've blocked out of your head? >> no, i remember it quite well. >> you went and had dinner at this restaurant. >> where are you going? >> i'm interested in what happened. >> no, you're not interested. what are you doing? what the hell are you doing? >> let me help you. there's no one talking to me. okay? you haven't got a worry. there's nobody talking to me. these are my questions for you which are based in my view -- >> now you want to know what happened that night? >> i'm curious, yeah. >> no, you're not curious. >> i am. because you were

i'm talking about crl, an outfit that provides drug companies and universities with everything they need new drugs up to the rats and mice these drugs need to be tested on. they make it easier and more efficient to test new drugs. they enable their clients to more quickly decide whether given early stage compound is worth developing or not, the go, no-go so to speak. plus, biopharma companies outsource more and more of their lab work, charles river sees an opportunity to take share. stocks went up about $3 or 8% since the last time we spoke. and even though it jumped over a dollar today, i don't know, we've got to find out whether there's more upside. let's talk to james foster, the chairman, president, and ceo of charles river laboratories. welcome back to "mad money." >> nice to be back, jim. >> well, sir, first, i was reading through your excellent presentation from october 31st, not the one you just did, but where you're talking about being very conservative about your earnings. and what i don't want to run into. our narrow guidance assumes a meaningful decline of earnings per share.